[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570535":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":13,"centralContacts":17,"locations":23,"responsibleParty":39,"collaborators":10,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":10,"eligibilityCriteria":47,"healthyVolunteers":48,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":55,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":10,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Nanfang Hospital, Southern Medical University","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Grade 3-4 aGVHD patients",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Grade 1-2 aGVHD patients",[14],{"name":15,"affiliation":5,"role":16},"Hua Jin","PRINCIPAL_INVESTIGATOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Yiming Sun","CONTACT","+86 13917802810","1224940802@qq.com",[24],{"facility":5,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Guangzhou","Other (Non U.s.)","510000","China","CN",{"type":32,"coordinates":33},"Point",[34,35],113.25,23.11667,{"lat":35,"lon":34},[38],{"name":19,"role":20,"phone":10,"phoneExt":10,"email":22},{"type":40,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100570535","tissue-resident-immune-cell-subsets-in-agvhd-100570535",false,"NCT06708507","Tissue-resident Immune Cell Subsets in aGVHD","A Prospective Study on the Correlation Between Tissue-resident Immune Cell Subsets and Graft-versus-host Disease Following Hematopoietic Stem Cell Transplantation.","Inclusion Criteria:\n\n1. Voluntarily sign the informed consent form;\n2. Age 16-65 years old\n3. Clinically diagnosed with GVHD for the first time\u002Freceiving GVHD treatment.\n\nExclusion Criteria:\n\n1. Have a history of other tumors\n2. With poor compliance or mental disorders\n3. Infected with HIV and HCV\n4. With uncontrolled HBV infection\n5. With other autoimmune diseases\n6. Those who are judged by the researcher to be unsuitable to participate in this study",true,"ALL","18 Years","65 Years",{"count":53,"type":54},40,"ESTIMATED","100 Days","OBSERVATIONAL","This is a prospective study investigating the role of tissue-resident immune cell subsets in the occurrence and progression of graft-versus-host disease following hematopoietic stem cell transplantation. Approximately 40 subjects(including 20 grade 3-4 aGVHD patients and 20 grade 1-2 aGVHD patients ).",[59,60],"Acute Graft-versus-Host Disease","Hematopoietic Stem Cell Transplantation","2024-11-25",{"date":63,"type":64},"2024-11-27","ACTUAL",{"date":66,"type":64},"2024-11-16",{"date":68,"type":54},"2025-05-31",{"name":5,"class":6},1]